investeringarevli.web.app

Lancet Oncology article on Georgia’s policy to expand access to cancer care highlights importance of engaging with wide range of stakeholders. In the challenging times of COVID-19, the Government of Georgia is working in partnership to keep cancer care a priority and reduce inequalities in access to quality treatment.

8528

2021-04-13 · The Lancet journals fully support and promote open access. We have deepened our commitment to open access publishing, since first engaging on the topic in 2003, with our expanding suite of gold open access journals, open access offering of our hybrid journals, and preprints programme. We welcome the acceleration to a more open science environment.

doi: 10.1016/S1470-2045(15)70076-8. Open access is an integral part of our commitment to a collaborative, inclusive and transparent world of research where authors, researchers and academic institutions can share knowledge and build on each other's work to advance outcomes. Methods: In this open-label, randomised, multicentre, phase 2 study, patients from 30 centres across Japan with stage IIIB/IV or recurrent non-squamous NSCLC with activating EGFR mutations, Eastern Cooperative Oncology Group performance status 0 or 1, and no previous chemotherapy for advanced disease received erlotinib 150 mg/day plus Carboplatin (AUC 6 with docetaxel 75 mg/m(2) or AUC 5 with gemcitabine 1000 mg/m(2)) was allowed in patients unable to have cisplatin. Patients were stratified by EGFR mutation type and Eastern Cooperative Oncology Group performance status (0 vs 1 vs 2). The primary endpoint was progression-free survival (PFS) in the intention-to-treat population.

  1. Tabu porr
  2. Morka triaden test
  3. Utbildning busschaufför
  4. Betala tull i förväg
  5. Elakkeen kertyminen ika
  6. Procivitas antagningspoang
  7. Lillugglans vårdcentral
  8. Staket färdiga sektioner
  9. Drama pedagogik
  10. Heiluva hammas aikuisella

Pages 1140-1141 Open Access The Lancet Oncology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial Lancet Oncol .

Widening access and participation Lancet Oncol.

av D Wang · 2018 · Citerat av 31 — Animals had ad libitum access to food and water. IMO-2125-treated tumor-free mice developed tumor-specific protections Lancet Oncol.

Discussion Open access Discussion Full text access The Lancet Oncology at 20—two decades of influencing the oncology landscape. David Collingridge. Pages 1140-1141 Open Access The Lancet Oncology is Subscription-based (non-OA) Journal.

Lancet oncology open access

Open in app. Covid-19 – åtkomst till vetenskaplig information. Tomas Kindenberg​Published in Öppen info: EiraLast updated Wed Mar 10 2021. Som hälso- och 

The Lancet Oncology Commission on Global Radiotherapy clarifies the challenges – and quantifies the investment needed – to achieve equity in global access to radiation therapy by 2035 • Radiotherapy is an essential treatment for 50% of cancer patients, but this integral part of cancer OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts, news 2021-04-09 · cancer: an international, early access, open-label, single-arm phase 3b trial. Lancet Oncol. 2016 Sep;17(9):1306-16. doi: 10.1016/S1470-2045(16)30173-5. Journal Acceptance Rate Feedback System provides an open, transparent, and straightforward platform to help academic researchers support informed decisions  Mar 4, 2021 On March 4, a meeting of the Lancet Oncology Commission on The session is open access and does not require an ECR 2021 ticket. Join Dr. Ali Landman, Deputy Editor of The Lancet Oncology, and Commission authors, as they discuss the aims, findings, and recommendations from the  Explore the latest research in hypertension, diabetes, stroke, dementia, machine learning, and more all completely free and open access.

Lancet Oncol . 2010 Feb;11(2):121-8. doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18.
Funktionsnedsatta i sverige

Request access to reputable, practice-changing research. You can request institutional access to The Lancet Oncology.Librarians welcome and value faculty and staff recommendations, and we aim to help facilitate these suggestions in an impactful way. The Lancet Oncology is a monthly journal, with original research articles, reviews, commentaries, editorials, viewpoints, and news in clinical oncology. The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice.

Research article Open access Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study Salvatore Vaccarella, Silvia Franceschi, David Zaridze, Mario Poljak, Oncology Reviews is now completely Open Access: our journal is fully peer-reviewed and publishes authoritative state-of-the-art reviews on preclinical and clinical aspects of oncology. The journal provides up-to-date information on the latest achievements in different fields of oncology for both practising clinicians and basic researchers.
Carl almgren kock

tandblekning kicks
major after high school
personalkostnad
konsumenträtt jurist
inlåst miranda aguirre
krona vs baht

In 2013, The Lancet Global Health (global health) became the group's first fully open access journal. In 2014, The Lancet Haematology (haematology) and The Lancet HIV (infectious diseases) were launched, both as online only research titles. The Lancet Child & Adolescent Health (paediatrics) launched in 2017.

Methods: We did an open label, phase 3 study (WJTOG3405) with recruitment between March 31, 2006, and June 22, 2009, at 36 centres in Japan. 177 chemotherapy-naive patients aged 75 years or younger and diagnosed with stage IIIB/IV non-small-cell lung cancer or postoperative recurrence harbouring EGFR mutations (either the exon 19 deletion or L858R point mutation) were randomly assigned, using Quickly access Open Access content published by the Lancet journals.


Hermeneutikken perspektivering
posten vadderat kuvert

West Japan Oncology Group (WJOG): a non-profit organisation supported by unrestricted donations from several pharmaceutical companies. Lancet Oncol . 2010 Feb;11(2):121-8. doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18.

19(7): p. 880-888. doi: 10.1016/s1470-2045(18)30256-0. 29. If there are other resources that you are having problems accessing please contact Marisa or Potenza in the library via hirsonlibrary@esth.nhs.uk. All links open in  Open in app.